lerodalcibep (LIB003) / LIB Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«12
  • ||||||||||  lerodalcibep (LIB003) / LIB Therap
    Enrollment closed, Trial completion date, Trial primary completion date:  Open-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003 (clinicaltrials.gov) -  Nov 15, 2019   
    P2b,  N=32, Active, not recruiting, 
    In 1 patient ADAs exceeded the level of assay sensitivity recommended by FDA with no impact on efficacy Enrolling by invitation --> Active, not recruiting | Trial completion date: Nov 2019 --> Mar 2020 | Trial primary completion date: Oct 2019 --> Mar 2020
  • ||||||||||  lerodalcibep (LIB003) / LIB Therap
    Enrollment open:  Phase 3 Study to Evaluate the Efficacy and Safety of LIB003 With Evolocumab in HoFH (clinicaltrials.gov) -  Nov 8, 2019   
    P3,  N=70, Enrolling by invitation, 
    Enrolling by invitation --> Active, not recruiting | Trial completion date: Nov 2019 --> Mar 2020 | Trial primary completion date: Oct 2019 --> Mar 2020 Not yet recruiting --> Enrolling by invitation